🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, risking penalties, legal action or prison.

Platform Reaction and Content Removal

Based on the social media company, the service has removed violative material and banned related hashtags and search suggestions. The company said it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with images of slimming results, positive testimonials and detailed guides for preparing or injecting at residence.

Within minutes of joining one community, a vendor posted contact information, where most transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Details and Pricing

Within these communities, messages display dark colored parcels with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant medical dangers”.